Regulatory Updates
🇪🇺 EMA Page 5EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 49–60 of 171 articles
EU Bolsters Trade Defenses Against Chinese Imports: A Pharmaceutical Market Analysis
EMA Approves New Medicines in January: Key Updates for Pharma Investors and BD Teams
CHMP Approves New Medicines: Key Decisions and Implications for the Pharmaceutical Industry
SFEE Highlights Significant Delays in Greek Patient Access to New Medicines
Medscape Education Leverages AI for Hematology at EHA 2026
OS Therapies' OST-HER2 Trial Hits 2.5-Year Survival Milestone in Osteosarcoma
Oxurion NV Expands GLP-1 and Peptide Research Services Amidst Market Growth
ASCO26: AstraZeneca's Camizestrant Data Aims to Sway FDA Approval
MaaT Pharma Q1 2026 Update: Financials, Business Progress, and Strategic Outlook
Naldemedine Approved in China for Opioid-Induced Constipation: A New Option for Cancer Supportive Care
OS Therapies' OST-HER2 Nears FDA Accelerated Approval for Osteosarcoma Amidst ASCO Data Presentation
Karyopharm's Selinexor Plus Ruxolitinib SENTRY Trial Data to be Presented at EHA 2026